3rd International Conference and Exhibition on Pharmaceutics & Advanced Drug Delivery Systems

March 4-5, 2020 | UK

The Global Pharmaceutical Sector is rapidly transforming with innovative therapeutic approaches and technological breakthroughs. In this fast-growing sector, Pharmaceutical Sciences 2020 thrives to gather like-minded people from various disciplines ofPharmaceutical and Healthcare Sectors in a single forum.

Spotlight

Novartis and Bayer are both charging exhorbitant prices for medicines in India as they continue their fight against the country's patent law that puts people over profits in the name of access to affordable medicines. These cases both could have a major impact on MSF's work in the field, as we rely heavily on affordable medicines produced in India to do our work.


OTHER PAST CONFERENCES

Drug Delivery and Nanomedicine

July 18-20, 2022 | USA

After a successful Drug Delivery Webinar 2021 during March and August 2021. it is our greatest pleasure to welcome you to the 5th Edition of Drug Delivery Webinar planned to be organized during July 18-20, 2022.

World Congress on Advanced Pharmacy and Clinical Research

June 1-2, 2022 | USA

A prestigious global platform that perfectly defines the architecture of Science and Technology. Helping people across globe to combat with the challenges the worlds is facing in technology , our events covers all the drastically challenging problems and reproduces unique solutions to it.

Transforming Drug Discovery through AI 2022

July 5-6, 2022 | USA

All big players in the pharma industry are concerned with AI adoption, the tech has become a strategic priority, among other things and all leading players of the pharmaceutical industry will be moving towards "platform-based drug design"

Biomarkers & Precision Oncology World Congress

June 20-22, 2022 | USA

Cambridge Healthtech Institute’s Seventeenth Annual Biomarkers & Precision Oncology World Congress is the longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines.

Spotlight

Novartis and Bayer are both charging exhorbitant prices for medicines in India as they continue their fight against the country's patent law that puts people over profits in the name of access to affordable medicines. These cases both could have a major impact on MSF's work in the field, as we rely heavily on affordable medicines produced in India to do our work.

resources